{"slug":"api-magentlab-com-api-calc-hfa-icos-bcr-abl-711ee1","title":"Lyon 2020 HFA-ICOS baseline cardiovascular risk before second- or third-generati","host":"api.magentlab.com","method":"POST","resource":"https://api.magentlab.com/api/calc/hfa_icos_bcr_abl","category":"other","description":"Lyon 2020 HFA-ICOS baseline cardiovascular risk before second- or third-generation multi-targeted kinase inhibitors for CML targeting BCR-ABL. Class is very_high, high, medium, or low from published very-high and high factors plus Medium 1/2 points (0–1 low, 2–4 medium, ≥5 high). Caller assigns the ","price_listed":0.005,"price_asked":0.007,"state":"overcharges","state_label":"Asked 1.4x its listed price for its own example","checks_7d":1,"answered_7d":1,"latency_ms_median":398,"reported_calls_30d":0,"reported_payers_30d":0,"networks":["eip155:8453"],"badge":"unverified","paid_checks_7d":0,"paid_ok_7d":0,"example_input":{"body":{"items":[{"abpi_le_0_9":false,"age_years":50,"arrhythmia":false,"arterial_thrombosis_with_tki":false,"arterial_vascular_disease":false,"bcr_abl_tki_mediated_lvsd":false,"ckd":false,"current_or_significant_smoker":false,"cvd_10y_risk_gt_20":false,"diabetes":false,"family_history_thrombophilia":false,"heart_failure_or_lvsd":false,"hyperlipidemia":false,"hypertension":false,"lvef_percent":60,"obesity":false,"pulmonary_arterial_hypertension":false,"qtc_ms":400,"sex":"female","venous_thromboembolism":false},{"abpi_le_0_9":false,"age_years":50,"arrhythmia":false,"arterial_thrombosis_with_tki":false,"arterial_vascular_disease":false,"bcr_abl_tki_mediated_lvsd":false,"ckd":false,"current_or_significant_smoker":false,"cvd_10y_risk_gt_20":false,"diabetes":false,"family_history_thrombophilia":false,"heart_failure_or_lvsd":false,"hyperlipidemia":false,"hypertension":false,"lvef_percent":60,"obesity":false,"pulmonary_arterial_hypertension":false,"qtc_ms":400,"sex":"female","venous_thromboembolism":false}]},"method":"POST","type":"http"},"output_schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"abpi_le_0_9":{"description":"Caller-assigned abnormal ankle-brachial pressure index (paper: ABPI ≤0.9). High. magent does not measure ABPI.","type":"boolean"},"age_years":{"description":"Age in years (integer 18-100). Lyon 2020 BCR-ABL table: ≥75 High; 65-74 Medium 2; 60-64 Medium 1 (paper row Age ≥60 years under the higher bands); <60 none. Bands do not stack. magent does not examine the patient.","type":"integer"},"arrhythmia":{"description":"Caller-assigned arrhythmia (paper: atrial fibrillation, atrial flutter, ventricular tachycardia, or ventricular fibrillation). Medium 2. magent does not read a rhythm strip.","type":"boolean"},"arterial_thrombosis_with_tki":{"description":"Caller-assigned arterial thrombosis associated with a BCR-ABL TKI. Very high. magent does not diagnose thrombosis.","type":"boolean"},"arterial_vascular_disease":{"description":"Caller-assigned arterial vascular disease (IHD, PCI, CABG, stable angina, TIA, stroke, or PVD). Very high. magent does not diagnose vascular disease.","type":"boolean"},"bcr_abl_tki_mediated_lvsd":{"description":"Caller-assigned BCR-ABL TKI-mediated LVSD. High. magent does not attribute LVSD to a TKI.","type":"boolean"},"ckd":{"description":"Caller-assigned chronic kidney disease (paper: eGFR <60 mL/min/1.73 m²). Medium 1. magent does not compute eGFR.","type":"boolean"},"current_or_significant_smoker":{"description":"Caller-assigned current smoker or significant smoking history. High on this BCR-ABL table (not Medium 1). magent does not take a smoking history.","type":"boolean"},"cvd_10y_risk_gt_20":{"description":"Caller-assigned paper row Cardiovascular disease 10-year risk score >20%. High. magent does not compute SCORE2, PCE, or any other 10-year CVD equation.","type":"boolean"},"diabetes":{"description":"Caller-assigned diabetes (paper: HbA1c >7.0% or >53 mmol/mol, or on treatment). Medium 1. magent does not diagnose diabetes.","type":"boolean"},"family_history_thrombophilia":{"description":"Caller-assigned family history of thrombophilia. Medium 1. magent does not take a family history.","type":"boolean"},"heart_failure_or_lvsd":{"description":"Caller-assigned heart failure or left-ventricular systolic dysfunction. High. magent does not diagnose heart failure.","type":"boolean"},"hyperlipidemia":{"description":"Caller-assigned hyperlipidemia (paper: non-HDL cholesterol >3.8 mmol/L or >145 mg/dL). Medium 1. magent does not assay lipids.","type":"boolean"},"hypertension":{"description":"Caller-assigned hypertension (paper: SBP >140 mmHg or DBP >90 mmHg, or on treatment). Medium 2. magent does not measure blood pressure.","type":"boolean"},"lvef_percent":{"description":"Left-ventricular ejection fraction in percent (10-80). <50 is High. This table has no 50-54 Medium 2 LVEF row; ≥50 adds no LVEF points. magent does not read an echocardiogram.","type":"number"},"obesity":{"description":"Caller-assigned obesity (paper: BMI >30 kg/m²). Medium 1. magent does not compute BMI.","type":"boolean"},"pulmonary_arterial_hypertension":{"description":"Caller-assigned pulmonary arterial hypertension (paper: peak systolic PAP ≥35 mmHg when estimated on echocardiography). High. magent does not estimate pulmonary pressure.","type":"boolean"},"qtc_ms":{"description":"QTc in milliseconds (300-700). ≥480 is High. Borderline Medium 2 is men 450≤QTc<480 and women 460≤QTc<480. magent does not measure QTc.","type":"number"},"sex":{"description":"Sex male or female. Selects the borderline QTc Medium 2 window (men 450≤QTc<480; women 460≤QTc<480). magent does not read an ECG.","type":"string"},"venous_thromboembolism":{"description":"Caller-assigned venous thromboembolism (DVT or PE). Medium 2. magent does not diagnose VTE.","type":"boolean"}},"required":["age_years","sex","lvef_percent","qtc_ms","arterial_vascular_disease","arterial_thrombosis_with_tki","heart_failure_or_lvsd","bcr_abl_tki_mediated_lvsd","abpi_le_0_9","pulmonary_arterial_hypertension","cvd_10y_risk_gt_20","current_or_significant_smoker","venous_thromboembolism","arrhythmia","hypertension","diabetes","hyperlipidemia","ckd","family_history_thrombophilia","obesity"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"},"history":[{"day":"2026-09-28","reachable":true,"status":402,"valid_402":true,"asked_usdc":0.007,"price_match":false,"latency_ms":398,"error":null}],"description_full":"Lyon 2020 HFA-ICOS baseline cardiovascular risk before second- or third-generation multi-targeted kinase inhibitors for CML targeting BCR-ABL. Class is very_high, high, medium, or low from published very-high and high factors plus Medium 1/2 points (0–1 low, 2–4 medium, ≥5 high). Caller assigns the 10-year CVD >20% threshold; magent does not compute that score. Not a medical device or treatment order.","last_updated":"2026-09-28T13:45:35.9Z","schemes":["exact"]}